Showing results for: ophthalmic surgery News
-
iSTAR Medical to attend the 34th International Congress of German Ophthalmic Surgeons (DOC)
We will be in Nuremberg next week at the DOC congress where Prof. Dr med. Marc Schargus (Asklepios Klinik Nord, Hamburg) will be presenting a meta-analysis from the STAR-I, STAR-II and STAR-III trials on patients with open-angle glaucoma who consistently achieve low diurnal intraocular pressures (IOP) of ≤18 mmHg up to two-years after implantation with MINIject. The Advanced Glaucoma ...
-
Prof. Dr med. Marc Schargus presents a pooled meta-analysis on MINIject at DOC 2022
A meta-analysis from the STAR-I, STAR-II and STAR-III trials on MINIject® was presented at the 34th International Congress of German Ophthalmic Surgeons (DOC) by Prof. Dr med. Marc Schargus (Asklepios Klinik Nord, Hamburg). It was entitled, “Patients with Open Angle Glaucoma Who Consistently Achieve Low Intraocular Pressures (≤18 mmHg) up to Two-years after Implantation with ...
-
The Bevan Commission Launches the Planned Care Innovation Programme
Responding to the urgent challenges presented by Covid-19, the Planned Care Innovation Programme is supporting people working in the health and care sector to take forward innovative ideas, opportunities, and ways of working to improve planned care services across Wales. Led by the Bevan Commission, Wales’ leading health and care think tank (hosted and supported by Swansea University), in ...
By MediWales
-
Is the CO2 fractional laser damaging to the skin
The best fractional CO2 laser machine is a minimally invasive treatment. It works by heating the dermis and epidermis with a fractional laser, causing microscopic columnar damage to the skin, activating fibroblasts, stimulating collagen remodelling reactions, thickening the dermis and achieving cosmetic results such as wrinkle reduction, skin rejuvenation and spot removal. Today the CO2 laser ...
-
Suntech Announces Commitment to Action at 2012 Clinton Global Initiative Annual Meeting to Power Hospital in the DRC
Suntech Power Holdings Co., Ltd. (NYSE: STP), the world's largest producer of solar panels, today announced that it will create a Commitment to Action as part of the Clinton Global Initiative (CGI) Annual Meeting to help power the Panzi Hospital in Bukavu, Democratic Republic of the Congo (DRC). Suntech will donate up to 300 kilowatts of solar panels to the hospital, which will significantly ...
-
CO2 fractional laser in cosmetic dermatology
The best CO2 fractional laser machine is a common cosmetic treatment, commonly used for skin treatment such as mole removal, flat warts, acne pit scars, etc. It can also be used for facial rejuvenation such as wrinkle removal, etc. CO2 laser skin resurfacing machine is a minimally invasive laser treatment technique. Traditional CO2 laser treatment has a long recovery period and greater damage, ...
-
CUSTOMFLEX® ARTIFICIALIRIS receives Transitional Pass‐through Payment Status
VEO Ophthalmics, LLC, today announced that the CUSTOMFLEX® ARTIFICIALIRIS has been approved by the Center for Medicare and Medicaid Services (CMS) for transitional pass‐through payment status, effective January 1, 2020. The HCPCS code for the CUSTOMFLEX® ARTIFICIALIRIS that is associated with pass‐through payment is: C1839 Iris prosthesis. The approval by CMS for transitional ...
-
Autocam Medical Recruiting for High-Paying Careers at MCC Job Fair
Autocam Medical, a global contract manufacturer of precision surgical and medical components and devices, announced Tuesday that they would be recruiting for a number of positions at the Montcalm Community College Job Fair on March 22nd. The company is looking to hire CNC Machinists, Manufacturing Engineers, and Secondary Operators that aspire to become Machinists. While the event is being held ...
-
Autocam Medical Announces Organizational Changes
Autocam Medical announced Tuesday that after an outstanding 32-year career, Tom O’Mara, Executive Vice President, has notified the company of his intent to retire at the end of the 2022 calendar year. Although Mr. O’Mara will be slowly relinquishing full-time responsibilities, he will remain in an advisory role with the company beyond December 31, 2022. Mr. O’Mara began his ...
-
Autocam Medical Recognizes Latest Apprenticeship Program Graduates
Autocam Medical, a global contract manufacturer of precision surgical and medical components and devices, presented 11 students with certificates of completion for their CNC Machinist Apprentice Program during a November 10th ceremony at the AMP Lab at Western Michigan University in Grand Rapids. The event, recognizing the company’s fourth class of graduates, was kicked off with a few ...
-
Bayer initiates phase III study to investigate aflibercept 8 mg in retinal vein occlusion
Global phase III QUASAR study will assess the efficacy and safety of aflibercept 8 mg in macular edema secondary to retinal vein occlusion (RVO) Study comes after positive data from the phase III PULSAR trial in neovascular (wet) age-related macular degeneration (nAMD) and phase II/III PHOTON trial in diabetic macular edema (DME) QUASAR is expected to enroll around 800 patients in 27 ...
By Bayer AG
-
Glaukos Announces FDA 510(k) Clearance of iPRIME
SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the iPRIME™ Viscodelivery System, a sterile, ...
-
Autocam Medical Building New $60 Million Site in West Michigan
Autocam Medical, a global contract manufacturer of precision, surgical and medical components and devices, announced today that it is investing $60 million through 2024 to expand its manufacturing footprint and capability in West Michigan. This new facility will continue to serve its customers by making products that improve people’s health. This investment includes a new ...
-
VEO Ophthalmics Collaborates with The Masket Foundation for Rare Disease Day
VEO Ophthalmics, LLC announced today that, in honor of Rare Disease Day, it is collaborating with the Masket Foundation to raise awareness of aniridia and treatment options for aniridia. Aniridia is a serious ophthalmic rare disease in which a patient’s iris does not develop properly. VEO Ophthalmics is the U.S. distributor for the CUSTOMFLEX® ARTIFICIALIRIS, a custom-made artificial ...
-
Basic ENT Surgery Set
Otorhinolaryngology is the medical specialty that deals with conditions of the ear, nose, and throat (ENT). Surtex Instruments manufacture the diverse instruments of the basic ENT surgery set to provide the best tools for the commonest diagnostic and therapeutic procedures in otolaryngology. The set includes three figures of Mod. Vienna Nasal Speculum with different blade lengths to offer ...
-
VEO Ophthalmics Launches CUSTOMFLEX ARTIFICIALIRIS in the U.S.
VEO Ophthalmics, LLC, today announced the launch of the CUSTOMFLEX ® ARTIFICIALIRIS, the first iris prosthesis available in the United States. The surgically implanted device received FDA approval on May 30, 2018 for use in children and adults for the treatment of iris defects resulting from congenital aniridia, acquired defects or other conditions associated with a completely or partially ...
-
An Easy, Predictable, and Simpler Way to Embolize Tumors
Instylla is now enrolling patients in a clinical trial for the world’s first hydrogel-based liquid embolic intended for the treatment of hypervascular tumors. A second initial application for its Embrace embolic therapy is hemorrhage control, where the product offers advantages in terms of simplicity, speed, and safety. Amar Sawhney and his teams, it seems, can make medical hydrogels do ...
-
Ivantis Completes Enrollment of International SPECTRUM Registry for Hydrus Microstent
SPECTRUM, the world’s largest single-device registry in ophthalmology, has completed enrollment. The announcement was made today by Ivantis Inc., a company dedicated to developing new and innovative solutions for glaucoma. SPECTRUM is a patient registry for the Hydrus® Microstent, a microinvasive glaucoma surgery (MIGS) device to treat patients with mild to moderate primary open-angle ...
-
MediPrint™ Ophthalmics Announces Promising Results From Its Primary Market Research
SAN DIEGO–(BUSINESS WIRE)–Today, MediPrint™ Ophthalmics, an emerging San Diego-based clinical stage eye care pharmaceutical company focused on helping protect sight, announces enlightening findings from its primary market research with optometrists and ophthalmologists related to contact lens drug delivery and its proprietary pipeline of assets. Key learnings from the market ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you